The development of new anti-TB drugs would help to prevent and treat MDR-TB. Notably, moxifloxacin and gatifloxacin are being tested for shortening treatment in Phase III trials, while three novel ...

Following the success of recent clinical trials, several major infectious disease agencies updated treatment guidance for ...

This study aimed to calculate the incidence of AKI due to anti-TB drugs and analyze the outcomes and predictors of renal recovery. Methods: From 2006 to 2010, patients on anti-TB treatment were ...

The Health Ministry has dismissed media reports claiming a shortage of anti-tuberculosis (TB) drugs in India, labelling them as "incorrect and misleading". In a statement, the Ministry emphasised ...

TB is treated with antibiotics that must be taken for at least six months. Modern anti-TB drugs are extremely effective and, in nearly all cases, sufferers feel much better after the first two ...

Mycobacteria are the world's most deadly bacteria --c ausing infectious diseases including tuberculosis (TB), which alone kills more than one million people each year. New drugs to fight these ...

TB drug resistance occurs when mutations in the ... assisting clinicians in formulating personalized anti-infection treatment regimens, reducing the risk of drug resistance, and aiding in precise ...

Mtb is known for its ability to resist drugs and evade the human immune system ... His team will receive $1.3 million in funding for the next four years on this anti-TB project in addition to his ...

European tuberculosis surveillance report underscores the gravity of the situation in the WHO European region.1 Across 53 ...